Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion type Assertion NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_head.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion description "[Dual inhibition of EGFR and ERBB2 with lapatinib significantly reduced GBM proliferation in colony formation assays compared to cetuximab-mediated EGFR-specific inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_provenance.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion evidence source_evidence_literature NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_provenance.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion SIO_000772 22745588 NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_provenance.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion wasDerivedFrom befree-20140225 NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_provenance.
- NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_assertion wasGeneratedBy ECO_0000203 NP840055.RAQ22KSMsVg4DT8K59p9ONNHM-dURMS1Q4hZogo-q9EKQ130_provenance.